7.30
2.96%
0.21
Dopo l'orario di chiusura:
7.29
-0.010
-0.14%
Kezar Life Sciences Inc Azioni (KZR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | 7.00 | - | - |
Operating Expenses
|
31.45%
23.71
|
34.59 | 32.53 | 26.78 | 24.52 |
Interest Income/Expense |
0.25%
0.40
|
0.399 | 0.396 | 0.385 | 0.37 |
Operating Income/Loss |
31.45%
-23.71
|
-34.59 | -25.53 | -26.78 | -24.52 |
Income/Loss From Continuing Operations Before Tax |
32.86%
-21.66
|
-32.26 | 7.00 | -24.31 | -22.20 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
32.86%
-21.66
|
-32.26 | -23.10 | -24.31 | -22.20 |
Net Income/Loss
|
32.86%
-21.66
|
-32.26 | -23.10 | -24.31 | -22.20 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
117.75K%
72.80
|
0.0618 | 72.68 | 72.46 | 72.33 |
Diluted Average Shares |
117.75K%
72.80
|
0.0618 | 72.68 | 72.46 | 72.33 |
Basic Earnings Per Share |
31.82%
-0.30
|
-0.44 | -0.32 | -0.34 | -0.31 |
Diluted Earnings Per Share |
31.82%
-0.30
|
-0.44 | -0.32 | -0.34 | -0.31 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):